Compare ADMA Biologics Inc (ADMA) vs OneSpan Inc (OSPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs OneSpan Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while OneSpan Inc trades at $16.25 (market cap $600.69M). The key difference: ADMA Biologics Inc is far larger — about 3.7× OneSpan Inc's market cap, and OneSpan Inc pays a 3.19% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | OSPN | |
|---|---|---|
Market Cap | $2.22B | $600.69M |
Sector | Health | Technology |
52-Week High | $20.38 | $16.78 |
52-Week Low | $7.60 | $10.15 |
Enterprise Value | $2.29B | $569.77M |
Dividend Yield | — | 3.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →
